Metformin for Type 2 Diabetes with Chronic Kidney Disease
common.study.values.description
“Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease”
This is a proposal for a retrospective observational study of the safety of metformin use in patients with chronic kidney disease, compared to other commonly used diabetes drugs. It will be conducted using retrospective data from the New York City CDRN, Medicare administrate files, and New York State Medicaid administrative files, which will be linked and then deidentified prior to analysis.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Metformin
Newly Initiated and regular metformin dosage as prescribed by each patient's medical care provider
Drug - Sulfonylurea
Newly initiated and regular sulfonylurea dosage as prescribed by each patient's medical care provider
Drug - DPP-4 inhibitor
Newly initiated and regular DPP-4 inhibitor dosage as prescribed by each patient's medical care provider
Drug - SGLT2 inhibitor
Newly initiated and regular SGLT2 inhibitor dosage as prescribed by each patient's medical care provider
Drug - GLP1 receptor agonist
Newly initiated and regular GLP1 receptor agonist dosage as prescribed by each patient's medical care provider
participant.views.study.view.additional
participant.views.study.view.scientific-title
Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease
common.study.values.clinical-trial-id
NCT03921242
participant.views.study.view.id
e0RmNb
